Know2eat

What alpha-gpc may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedCognitive functionLimited evidence· 2 sources

Then, in order

About Alpha-GPC

A choline compound found naturally in cell membranes and made commercially from soy or sunflower lecithin. It crosses the blood-brain barrier more readily than choline salts, which is the basis of its use as a nootropic and a pre-workout ingredient.

Alpha-GPC is a licensed medicine for cognitive decline in some countries and a supplement in others, with a trial base concentrated in Italian studies of vascular dementia from the 1990s and 2000s. Sports use rests on small short studies of power output with inconsistent results. The reason it appears here with a warning rather than an endorsement is a 2021 analysis of a Korean national health insurance database, which found higher stroke incidence over ten years among people prescribed choline alfoscerate. That is observational and subject to confounding by indication — people prescribed it have cognitive problems, which themselves predict stroke — but it is a large signal in a very large dataset and it has not been resolved.

Sold as
Capsule, Powder, Component of pre-workout and nootropic blends, Prescription choline alfoscerate (some countries)
Also known as
L-alpha-glycerylphosphorylcholine, Choline alfoscerate, GPC

Regulation: A prescription medicine for cognitive disorders in Italy, South Korea and elsewhere; a dietary supplement in the US. No Tolerable Upper Intake Level exists specifically; the 3,500 mg/day choline upper limit is the nearest reference.

What the research used

The amounts, forms and durations published trials of Alpha-GPC actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Vascular cognitive impairment trials

    1200 mg

    Limited

    Oral, divided doses · 3–6 months

    Mostly Italian trials, several open-label or with active rather than placebo comparators. Independent replication outside those groups is limited.

  • Studied for Power and strength studies

    300–600 mg

    Limited

    Single dose before exercise, or daily · Single dose to 6 days

    Very small studies — often fewer than 20 participants — with mixed results on jump power and force production. Several were supported by ingredient suppliers.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.

  • Before exercise

    Limited

    Sports studies dosed 30–60 minutes before exercise, which is where the acute power measurements were taken. Whether that timing matters has not been tested against alternatives.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

The evidence in depth

Best supported: Limited

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Trials in vascular cognitive impairment report improvements on clinical rating scales, but the studies are small, largely from one country, and often lack placebo controls. Evidence in healthy adults is thinner still.

What may be going on: Alpha-GPC delivers choline across the blood-brain barrier for acetylcholine synthesis and membrane phospholipid production.

Limited evidence. Early human work, or mostly lab and animal research.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Some very small studies report increased peak force or jump power after a single dose. Sample sizes are tiny, findings are inconsistent between studies, and supplier involvement is common.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Worth knowing

    An unresolved stroke signal in a large observational dataset

    A ten-year analysis of a Korean national health insurance cohort found higher stroke incidence among people prescribed choline alfoscerate. Confounding by indication is a real alternative explanation, and no randomised trial has examined it. Until it is resolved, this is a meaningful uncertainty for anyone taking alpha-GPC long term, especially with existing cardiovascular risk.

  • Worth knowing

    TMAO production

    As a choline source, alpha-GPC contributes to gut bacterial trimethylamine production and TMAO formation — the same pathway that underlies the cardiovascular questions attached to choline supplements generally, and a proposed explanation for the stroke observation.

  • Interaction

    Additive cholinergic effects

    Interacts withDonepezil, rivastigmine, anticholinergic medicines

    Effects may add to cholinesterase inhibitors such as donepezil and to other cholinergic drugs. Anticholinergic medicines work in the opposite direction.

  • Worth knowing

    Common in blends at undisclosed doses

    Alpha-GPC frequently appears inside proprietary pre-workout and nootropic blends where the individual amount is not stated, making the actual exposure unknown.

Evidence ratings on this page: 2 limited evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Alpha-GPC, or a dose to follow.